About Bone morphogenetic protein 5
Bone morphogenetic protein 5 (BMP5) is a protein
from Homo sapiens identified by UniProt accession
P22003, 454 residues long.
MolForge cross-references it against 0 known binders and
657 disease associations.
Target properties
| Protein name | Bone morphogenetic protein 5 |
| UniProt accession | P22003 |
| Gene | BMP5 |
| Organism | Homo sapiens |
| Length | 454 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (657)
Diseases linked to this target (Open Targets).
- heel bone mineral density · score 0.52
- bone quantitative ultrasound measurement · score 0.48
- brain volume measurement · score 0.45
- colorectal cancer · score 0.42
- urate measurement · score 0.41
- sitting height measurement · score 0.38
- body height · score 0.38
- bone density · score 0.36
- osteoarthritis · score 0.34
- cystatin C measurement · score 0.34
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P22003-F1 | alphafold | PREDICTED | 74.58 | — |
Amino-acid sequence (454 residues)
MHLTVFLLKG IVGFLWSCWV LVGYAKGGLG DNHVHSSFIY RRLRNHERRE IQREILSILG LPHRPRPFSP GKQASSAPLF MLDLYNAMTN EENPEESEYS VRASLAEETR GARKGYPASP NGYPRRIQLS RTTPLTTQSP PLASLHDTNF LNDADMVMSF VNLVERDKDF SHQRRHYKEF RFDLTQIPHG EAVTAAEFRI YKDRSNNRFE NETIKISIYQ IIKEYTNRDA DLFLLDTRKA QALDVGWLVF DITVTSNHWV INPQNNLGLQ LCAETGDGRS INVKSAGLVG RQGPQSKQPF MVAFFKASEV LLRSVRAANK RKNQNRNKSS SHQDSSRMSS VGDYNTSEQK QACKKHELYV SFRDLGWQDW IIAPEGYAAF YCDGECSFPL NAHMNATNHA IVQTLVHLMF PDHVPKPCCA PTKLNAISVL YFDDSSNVIL KKYRNMVVRS CGCH
Explore Bone morphogenetic protein 5 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets